Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
NPJ Vaccines|March 30, 2024
Highly stable and immunogenic CMV T cell vaccine candidate developed using a synthetic MVA platformMarcal Yll-Pico, Yoonsuh Park, Joy Martinez, et al.
Iscience|May 31, 2022
COH04S1 and beta sequence-modified vaccine protect hamsters from SARS-CoV-2 variantsFelix Wussow, Mindy Kha, Katelyn Faircloth, et al.
Plos Pathogens|November 21, 2014
Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complexFelix Wussow, Flavia Chiuppesi, Joy Martinez, et al.
Journal of Virology|December 31, 2010
Vaccine-induced control of viral shedding following rhesus cytomegalovirus challenge in rhesus macaquesKristina Abel, Joy Martinez, Yujuan Yue, et al.
Blood|October 21, 2016
MVA vaccine encoding CMV antigens safely induces durable expansion of CMV-specific T cells in healthy adultsCorinna La Rosa, Jeff Longmate, Joy Martinez, et al.
Research Square|July 24, 2020
Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus PlatformFlavia Chiuppesi, Marcela d'Alincourt Salazar, Heidi Contreras, et al.
Biorxiv : the Preprint Server for Biology|September 21, 2021
Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human PrimatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
NPJ Vaccines|January 22, 2022
Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primatesFlavia Chiuppesi, Vu H Nguyen, Yoonsuh Park, et al.
Pageof 3